Free Trial
OTCMKTS:NEVPF

Abliva AB (publ) (NEVPF) Stock Price, News & Analysis

Abliva AB (publ) logo
$0.03 0.00 (0.00%)
As of 05/2/2025

About Abliva AB (publ) Stock (OTCMKTS:NEVPF)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.03
52-Week Range
$0.01
$0.04
Volume
N/A
Average Volume
4,445 shs
Market Capitalization
$11.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abliva AB (publ), a clinical-stage biotech company, develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

Receive NEVPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abliva AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

NEVPF Stock News Headlines

Pharming announces public cash offer to shareholders of Abliva AB
Stillfront Group publ AB (SFRG)
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
Probi AB
IVSXF Investor AB (publ)
Interfox Resources publ AB (IFOX)
See More Headlines

NEVPF Stock Analysis - Frequently Asked Questions

Abliva AB (publ)'s stock was trading at $0.0360 at the start of the year. Since then, NEVPF stock has decreased by 22.2% and is now trading at $0.0280.
View the best growth stocks for 2025 here
.

Shares of NEVPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:NEVPF
CIK
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-9,010,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10,000.00
Price / Cash Flow
N/A
Book Value
$0.02 per share
Price / Book
1.40

Miscellaneous

Free Float
N/A
Market Cap
$11.28 million
Optionable
Not Optionable
Beta
-1.18
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:NEVPF) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners